Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

2338 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells

Grinshtein N, Datti A, Fujitani M, Uehling D, Prakesch M, Isaac M, Irwin MS, Wrana JL, Al-Awar R, Kaplan DR.

Cancer Res. 2011 Feb 15;71(4):1385-95. doi: 10.1158/0008-5472.CAN-10-2484. Epub 2011 Feb 8.

Tourette's syndrome and type 2 bipolar disorder

Fonseca L, Damásio J, Magalhães M, Duarte J.

J Neuropsychiatry Clin Neurosci. 2011 Winter;23(1):E26. doi: 10.1176/jnp.23.1.jnpe26.

The metabolic landscape of Tourette syndrome: learning to view the elephant as an elephant

Kompoliti K.

Neurology. 2011 Mar 15;76(11):938-9. doi: 10.1212/WNL.0b013e3182104140. Epub 2011 Feb 9.

DNA repair: the culprit for tumor-initiating cell survival?

Mathews LA, Cabarcas SM, Farrar WL.

Cancer Metastasis Rev. 2011 Jun;30(2):185-97. doi: 10.1007/s10555-011-9277-0.

Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome

Ackermans L, Duits A, van der Linden C, Tijssen M, Schruers K, Temel Y, Kleijer M, Nederveen P, Bruggeman R, Tromp S, van Kranen-Mastenbroek V, Kingma H, Cath D, Visser-Vandewalle V.

Brain. 2011 Mar;134(Pt 3):832-44. doi: 10.1093/brain/awq380.

Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders

Paba S, Frau R, Godar SC, Devoto P, Marrosu F, Bortolato M.

Curr Pharm Des. 2011;17(2):151-67. doi: 10.2174/138161211795049589.

Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome

van Meerbeeck P, Behar C, Czernecki V, Roze E, Deniau E, Hartmann A.

Mov Disord. 2011 Apr;26(5):928-9. doi: 10.1002/mds.23521. Epub 2011 Mar 2.

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders

Vaccarino FM, Stevens HE, Kocabas A, Palejev D, Szekely A, Grigorenko EL, Weissman S.

Neuropharmacology. 2011 Jun;60(7-8):1355-63. doi: 10.1016/j.neuropharm.2011.02.021. Epub 2011 Mar 1.

Recent advances in Tourette syndrome

Bloch M, State M, Pittenger C.

Curr Opin Neurol. 2011 Apr;24(2):119-25. doi: 10.1097/WCO.0b013e328344648c.

Translocation breakpoint at 7q31 associated with tics: further evidence for IMMP2L as a candidate gene for Tourette syndrome

Patel C, Cooper-Charles L, McMullan DJ, Walker JM, Davison V, Morton J.

Eur J Hum Genet. 2011 Jun;19(6):634-9. doi: 10.1038/ejhg.2010.238. Epub 2011 Mar 9.

[Fluoxetine-induced tics in a child]

Ceylan MF, Akca ÖF.

Turk Psikiyatri Derg. 2011 Spring;22(1):61-2.

[Psychometric attributes of the Spanish version of A-TAC screening scale for autism spectrum disorders]

Cubo E, Sáez Velasco S, Delgado Benito V, Ausín Villaverde V, García Soto XR, Trejo Gabriel Y Galán JM, Martín Santidrián A, Macarrón JV, Cordero Guevara J, Benito-León J, Louis ED.

An Pediatr (Barc). 2011 Jul;75(1):40-50. doi: 10.1016/j.anpedi.2011.01.008. Epub 2011 Mar 23.

Paligraphia and written jocularity in Gilles de la Tourette syndrome

Cavanna AE, Ali F, Rickards H.

Mov Disord. 2011 Apr;26(5):930-1. doi: 10.1002/mds.23495. Epub 2011 Mar 21.

European clinical guidelines for Tourette syndrome and other tic disorders

Roessner V, Rothenberger A, Rickards H, Hoekstra PJ.

Eur Child Adolesc Psychiatry. 2011 Apr;20(4):153-4. doi: 10.1007/s00787-011-0165-5.

European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment

Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, Czernecki V, Robertson MM, Martino D, Munchau A, Rizzo R; ESSTS Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Apr;20(4):155-71. doi: 10.1007/s00787-011-0164-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias